PYX Resources: Achieving volume and diversification milestones. Watch the video here.
Went to my local Iceland store today for a few items. Its only a small branch, but there were 2 large chest freezers marked up specifically for My Protein products and both were full with a good range of products.
Assume this is duplicated across all the Iceland stores. If so, must be doing some decent volume.
Impressive range - hadn't seen these products before.
Good point.
However Downing also have opened a new IHT Fund this tax year, which has been targeting new investors money and their on line prospectus shows companies that they plan to invest in including RFX!!!
Yeah Otus Capital finally declare their massive reduction in holding from 9.61% to 4.95%.
Good news, share price can now hopefully recover.
Got to be a takeover target at this level?
Ludicrous over reaction on opening, down 45%.
The update is just a re-hash of January's update. The bank waiver has been extended for another year.
Yes, need to material export order to be fulfilled, but mid single digit growth and US business started positively.
Okay work to be done as results H2 loaded.
Got to be a takeover target if this management team can't fix a company with mainly non discretionary healthcare spend, surely?
Yes saw the Holding RNS - looks like I was wrong in believing that Downing were reducing their position.
Up from 9.99% to 10.17%.
Lets hope they continue to see value here and add more for their IHT fund.
THG PLC ("THG" or the "Group") will publish its first quarter trading update for the period ended 31 March 2024 on 23 April 2024.
The THG management team will host a conference call for analysts and institutional investors on 23 April 2024 at 08:30 BST and registration for this can be accessed via the following link:
https://stream.brrmedia.co.uk/broadcast/6620e6b140524def7b49c88e
Agree with your thoughts Rivaldo. Share price should hold up well with the smooth sale..
Clearly there was strong Institutional Investor demand at 225p with 6.7m shares sold, significantly higher than the 4.44m shares floated in yesterday's RNS.
An hour later and another RNS.
Fonix to take opportunity to buy back 1m shares using surplus cash - to be held in treasury.
Https://uk.advfn.com/p.php?pid=nmona&article=93681279
To "meet institutional demand".
- I guess price will drive down tomorrow...
Share price is manipulated by the big boys. Pushed up yesterday on excellent results to suck new money in. Today driven back down by funds / shorters using algo trades.
They drive price down hard and shake out cheap shares, then when they've acquired enough, push price back up again. Nothing has changed with Tesco business, just games being played.
A great opportunity to buy more (as I have done) cheaply, ready for decent dividend and or move back over 300p
Downing hold 3.18m shares in RFX (10.05% of total shares in circulation), so clearly if they are disposing of these shares over time, they are obliged to notify the market....
Ironically, whilst they are winding up their Strategic Micro Cap fund and retuning monies to investors, they are touting for new investors to put money into their AIM Extra Planning Service ISA (an IHT scheme) where the brochure shows companies that they plan to invest in, including....and you guessed it......RFX!!
I'm expecting Ramsdens to rise as this year progresses..
Has the large seller (Downing Micro Cap fund?) finally finished selling? Would be nice to get a Holding RNS to confirm...
"Profit growth and lower debt: a lot to like about Venture Life"
Simon Thompson's summary:
For the year ahead, house broker Cavendish expects adjusted operating profit margins to increase one percentage point to 8.5 per cent, which on 7 per cent higher revenue of £55mn could drive up operating profit 20 per cent to £4.7mn. Furthermore, estimated free cash flow of £6.1mn (2024) and £7.8mn (2025) is predicted to slash net debt from £13.7mn to £9.2mn (2024) and £1.9mn (2025). In other words, the £47mn market capitalisation company is on course to be almost debt free next year when it is forecast to deliver underlying operating profit of £6.1mn on revenue of £59.4mn.
The operational improvement in the business and balance sheet deleveraging were key bull points when I suggested buying the shares, at 30.5p (‘Investors are too cautious with this cash-generative company’, 26 September 2023). That’s still the case. Cavendish’s fair valuation of 68p a share is not unreasonable, representing a target forward price/earnings (PE) ratio of 10 for 2025. Buy.
Good results, perhaps people expected more information on outlook?
Today's price movement is just traders in and out from yesterday.
Will need additional fresh buyers to get this into the 40p's IMO. I reckon this will happen over next 2 weeks.
Simon Thompson in Investors Chronicle is a fan and regularly reviews and tips this as a buy.
Lovely tree shake this morning and opportunity to buy cheaply.
Just bought back in here at £1.17 in readiness for FY trading update. Last year was out 20th April.
Of course revenue may still be lower than previous years, but margins and profits are definitely improving.
Minimal net debt. Cash conversion for Xmas period should be strong.
Just watched the November presentations and the new CFO looks really focused on improving profitability, through simplicity (reduced SKUs etc) which I like.